C4 Therapeutics

IPO

Protein Degraded. Disease Targeted. Lives Transformed.

Public · Watertown, United States · Founded 2015 · $170.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$170.0M
Last Round
$170.0M Series BJun 2020
Rounds
1
Type
Public

About

C4 Therapeutics is a clinical-stage biopharma pioneering targeted protein degradation (TPD). Founded 2015. Lead TPD platform focused on novel target selection.

Summary

C4 Therapeutics is a Biotech company based in Watertown, United States, founded in 2015. It has raised $170.0M in total across 1 round, most recently a $170.0M Series B round in Jun 2020. Investors include Bain Capital Life Sciences, Adage Capital and Axil Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketOct 2025

Sign up to see all 3 rounds

Series B through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

C4 Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/c4-therapeutics"><img src="https://indexed.vc/api/badge/company/c4-therapeutics" alt="C4 Therapeutics on Indexed.vc" width="260" height="76" /></a>